期刊文献+

醛固酮合成酶基因多态性(C/T)与高血压患者左室肥厚相关性研究 被引量:5

Aldosterone Synthase Gene Polymorphisms and Left Ventricular Hypertrophy in Hypertensive Patients
下载PDF
导出
摘要 目的 研究原发性高血压患者醛固酮合成酶CYP11B2 (- 344C/T)多态性与左室肥厚的关系。方法 应用多聚酶链式反应 (PCR)、限制性内切酶方法检测 4 2 0例原发性高血压患者CYP11B2 (- 344C/T)基因型。用M型超声心动图测量舒张末期左心室内径 (LVDd) ,左心室后壁厚度 (LVPWT) ,舒张末期室间隔厚度 (INSTd)。结果 三组基因型间醛固酮 (ALD)浓度差异无显著性 ;左室肥厚 (LVH)与非左室肥厚 (NLVH)组基因型、等位基因频率分布差异无显著性 (P >0 0 5 )。LVH组血浆ALD浓度显著高于NLVH组 (15 6 .95± 4 7.5 5vs 14 6 .33± 4 5 2 9,P <0 0 5 ) ;按ALD水平四分位数分成四级 ,OR值随醛固酮水平的增加而递增 ,呈现明显的剂量反应关系。结论 醛固酮合成酶CYP11B2 (- 344C/T)多态性与左室肥厚无关 ;ALD水平是高血压患者左室肥厚的危险因素。 Objective To study the relationship of gene polymorphism of aldosterone synthase CYP11B2(-344C/T)and left ventricular hypertrophy in hypertensive patients. Methods The genotype of CYP11B2 was monitored by polymerase chain reaction (PCR-RFLP) in 420 hypertensive. LVDd, LVPWT and INSTd of left ventricular were detected by echocardio graphy. Results The genotype frequence rate of TT,CT,CC and allele frequency distribution had no significant difference in left ventricular hypertrophy and non-left ventricular hypertrophy(P>0.05); the plasma aldosterone levels in LVH group were higher than in NLVH group(156.95±47.55 vs 146.33±45.29,P<0.05); the odds ratio for left ventricular hypertrophy was higher corresponding with the aldosterone levels. Conclusion No assoeiation between aldosterone synthase gene polymorphisms and LVH was found. The plasma levels of aldosterone may be related to LVH in hypertensive patients.
出处 《高血压杂志》 CSCD 2004年第4期315-318,共4页 Chinese Journal of Hypertension
关键词 醛固酮合成酶 基因多态性 高血压 左室肥厚 并发症 aldosterone synthase gene polymorphism hypertension hypertrophy left ventricular
  • 相关文献

参考文献12

  • 1Mathew J,Sleight P,Lonne E,et al.Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by angiotension-converting enzyme inhibitor ramipril[J].Circulation,2001,104:1615-1621.
  • 2Kupari M,Hautanen A,Lankinen L,et al.Associations between human aldosterone synthase(CYP11B2) gene polymorphisms and left ventricular size,mass,and function[J].Circulation,1998,97:569-575.
  • 3Tamaki S,Iwai N,Tsujita Y,et al.Genetic polymorphism of CYP11B2 gene and hypertension in Japanese[J].Hypertension,1999,,33:266-270.
  • 4Hautanen A,Toivanen P,Manttari M,et al.Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction[J].Circulation,1999,100:2213-2218.
  • 5陈爱华,张文秀,唐晓明,李志樑,陆青,钱学贤.醛固酮合成酶基因多态性与高血压及左室肥厚的关系[J].中华内科杂志,2002,41(5):298-301. 被引量:38
  • 6Schunkert H,Henstenberg C,Holmer SR,et al.Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure [J].Circulation,1999,99(17):225.
  • 7de Simone G,Pasanisi F,Contaldo F.Link of nonhemodynamic factors to he modynamic determinants of lefe ventricular hypertrophy[J].Hypertension,2001,38:13-18.
  • 8Caldweone A,Takahashi N,Izzo NJ,et al.Pressure and volume induced left ventricular hypertrophy are associated with distint myocyte phenotype and differntial induction of peptide growth factor mRNAs[J].Circulation,1995,92:2385-2390.
  • 9Duprez DA,Bauwens FR,De Buyzere ML,et al.Influence of arterial blood pressure and aldosterone on ventricular hypertrophy in moderate essential hypertension [J].Am J Cardiol,1993,71(3):17A.
  • 10Navarro-Lopez F,Coca A,Pare JC,et al.Left ventricular hypertrophy in asymptomatic essential hypertension:its relationship with aldersterone and the increase in sodium-proton exchanger activity[J].Eur Heart J,1993,14 (suppl J):38.

二级参考文献9

  • 1Devereux RB, Koren MJ, de Simone G, et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J ,1993, 14 Suppl D:8-15.
  • 2Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.J Clin Invest, 1990 , 86:1343-1346.
  • 3Kupari M, Hautanen A, Lankinen L, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 1998,97:569-575.
  • 4Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 1998,32:198-204.
  • 5Tamaki S,Iwai N,Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 1999, 33:266-270.
  • 6Hautanen A, Toivanen P, Manttari M,et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.Circulation, 1999,100:2213-2218.
  • 7Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res, 2001, 24:105-109.
  • 8White PC, Hautanen A, Kupari M. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol, 1999,69:409-412.
  • 9Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest, 1994, 93:2578-2583.

共引文献37

同被引文献24

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部